Contraception · Adverse Effects
Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study
Meaidi A, Mascolo A, Sessa M, Toft-Petersen AP, Skals R, Gerds TA, Wessel Skovlund C, Morch LS, Rossi F, Capuano A, Lidegaard O, Torp-Pedersen C
Cite this paper
Meaidi, A., Mascolo, A., Sessa, M., Toft-Petersen, A. P., Skals, R., Gerds, T. A., Wessel Skovlund, C., Morch, L. S., Rossi, F., Capuano, A., Lidegaard, O., & Torp-Pedersen, C. (2023). Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study. BMJ (Clinical research ed.), 382, e074450. https://doi.org/10.1136/bmj-2022-074450
Meaidi A, Mascolo A, Sessa M, Toft-Petersen AP, Skals R, Gerds TA, Wessel Skovlund C, Morch LS, Rossi F, Capuano A, Lidegaard O, Torp-Pedersen C. Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study. BMJ (Clinical research ed.). 2023;382:e074450. doi:10.1136/bmj-2022-074450
Meaidi, Amani, et al. "Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study." BMJ (Clinical research ed.), vol. 382, 2023, pp. e074450.
For EndNote, Zotero or Mendeley:
Open access
No open license is recorded for this paper. Reuse terms are set by the publisher.
Open Access
Free full text on PubMed Central (PMC10480689)